HomeNEUP • NASDAQ
add
Neuphoria Therapeutics Inc
Previous close
$4.05
Day range
$3.98 - $4.09
Year range
$3.65 - $21.40
Market cap
21.70M USD
Avg Volume
56.34K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | 2022info | Y/Y change |
|---|---|---|
Revenue | 6.06M | 552.46% |
Operating expense | 7.65M | 40.65% |
Net income | -21.76M | -150.19% |
Net profit margin | -359.34 | 61.65% |
Earnings per share | -2.36 | -23,500.00% |
EBITDA | -16.67M | -78.55% |
Effective tax rate | 0.87% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | 2022info | Y/Y change |
|---|---|---|
Cash and short-term investments | 33.56M | 17.77% |
Total assets | 65.31M | 20.36% |
Total liabilities | 8.40M | 25.97% |
Total equity | 56.91M | — |
Shares outstanding | 1.35B | — |
Price to book | 101.25 | — |
Return on assets | -18.40% | — |
Return on capital | -20.74% | — |
Cash Flow
Net change in cash
| (AUD) | 2022info | Y/Y change |
|---|---|---|
Net income | -21.76M | -150.19% |
Cash from operations | -21.76M | -188.58% |
Cash from investing | 621.70K | 875.13% |
Cash from financing | 27.00M | -14.45% |
Net change in cash | 5.07M | -78.83% |
Free cash flow | -11.89M | -315.64% |
About
Founded
1996
Headquarters
Website
Employees
8
